Quarterly report pursuant to Section 13 or 15(d)

Financing Arrangements (Tables)

v2.4.0.8
Financing Arrangements (Tables)
9 Months Ended
Sep. 30, 2014
Debt Disclosure [Abstract]  
Summary of carrying values and coupon rates on financing arrangements
The carrying values and the fixed contractual coupon rates of the Company's financing arrangements as of September 30, 2014 and December 31, 2013 were as follows (in thousands):

 
September 30, 2014
 
December 31, 2013
2019 Convertible Senior Notes
 
 
 
     Principal amount outstanding
$
245,000

 
$

     Unamortized discount
(51,369
)
 

          Net carrying amount
193,631

 

Convertible notes payable, Viking Therapeutics, Inc.
337

 

Current portion notes payable, 8.64%, due August 1, 2014

 
6,642

Current portion notes payable, 8.9012%, due August 1, 2014

 
2,467

Total notes payable
$
193,968

 
$
9,109